European Medical Journal

T-Cell Receptor Clonotype Biomarkers in Cutaneous Lymphomas

Discover how T-cell receptor clonotype biomarkers help identify high-risk MF/SS patients, improving risk stratification and ...
Monthly Prescribing Reference

First T-Cell Receptor Gene Therapy Approved for Synovial Sarcoma

Afamitresgene-autoleucel is an autologous T-cell immunotherapy designed to target cancer cells in solid tumors expressing melanoma-associated antigen A4. The Food and Drug Administration (FDA) has ...
Medscape

Decoding T-Cell Receptor Clonotypes in Aggressive CTCL

According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...
GEN

Streamlining CAR/TCR T-Cell Therapy Manufacturing

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...
The Scientist

Inducible CAR T Cells Target Solid Tumors Better

Chimeric antigen receptor (CAR) T cell therapy leverages patients’ immune systems to fight cancer. This immunotherapy greatly expanded treatment options for cancers like leukemia and lymphoma. However ...

Azalea Therapeutics Launches with $82 Million Financing to Redefine Precision Genomic Medicines by Engineering Cells Directly Inside Each Patient

First company to enable precision in vivo genome engineering, combining both cell-specific delivery and programmable, locus-specific gene insertion, with the potential to achieve physiological, ...